Yüklüyor......
Prognostic Role of HER2 Status and Adjuvant Trastuzumab Treatment in Lymph Node-Negative Breast Cancer Patients - a Retrospective Single Center Analysis
BACKGROUND: The natural course of traditionally prognostically unfavorable human epidermal growth factor receptor 2 (HER2)-positive breast cancer has been changed by anti-HER2 therapy. It is not clear whether the prognosis for HER2-positive patients treated with adjuvant trastuzumab differs from tha...
Kaydedildi:
| Yayımlandı: | Breast Care (Basel) |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
S. Karger GmbH
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5290447/ https://ncbi.nlm.nih.gov/pubmed/28228707 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000454690 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|